Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium

Background: The incidence of oropharyngeal and oral tongue cancers has increased over the last 20 years which parallels increased use of marijuana among individuals born after 1950. Methods: A pooled analysis was conducted comprising individual-level data from nine case–control studies from the United States and Latin America in the INHANCE consortium. Self-reported information on marijuana smoking, demographic, and behavioral factors was obtained from 1,921 oropharyngeal cases, 356 oral tongue cases, and 7,639 controls. Results: Compared with never marijuana smokers, ever marijuana smokers had an elevated risk of oropharyngeal [adjusted OR (aOR), 1.24; 95% confidence interval (CI): 1.06–1.47] and a reduced risk of oral tongue cancer (aOR, 0.47; 95% CI, 0.29, 0.75). The risk of oropharyngeal cancer remained elevated among never tobacco and alcohol users. The risk of oral tongue cancer was reduced among never users of tobacco and alcohol. Sensitivity analysis adjusting for potential confounding by HPV exposure attenuated the association of marijuana use with oropharyngeal cancer (aOR, 0.99; 95% CI, 0.71–1.25), but had no effect on the oral tongue cancer association. Conclusions: These results suggest that the association of marijuana use with head and neck carcinoma may differ by tumor site. Impact: The associations of marijuana use with oropharyngeal and oral tongue cancer are consistent with both possible pro- and anticarcinogenic effects of cannabinoids. Additional work is needed to rule out various sources of bias, including residual confounding by HPV infection and misclassification of marijuana exposure. Cancer Epidemiol Biomarkers Prev; 23(1); 160–71. ©2013 AACR.

[1]  R. L. Collins,et al.  The influence of marijuana and alcohol use on condom use behavior: findings from a sample of young adult female bar drinkers. , 2012, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[2]  R. Miech,et al.  Trends in U.S., past-year marijuana use from 1985 to 2009: an age-period-cohort analysis. , 2012, Drug and alcohol dependence.

[3]  A. Bryan,et al.  Marijuana use and risky sexual behavior among high-risk adolescents: trajectories, risk factors, and event-level relationships. , 2012, Developmental psychology.

[4]  B. Graubard,et al.  Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.

[5]  Christian Munk,et al.  Trends in head and neck cancer incidence in Denmark, 1978–2007: Focus on human papillomavirus associated sites , 2011, International journal of cancer.

[6]  A. Hohmann,et al.  The endocannabinoid system and cancer: therapeutic implication , 2011, British journal of pharmacology.

[7]  D. Hayes,et al.  Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H. Penefsky,et al.  Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells , 2010, Pharmacology.

[9]  D. Winn,et al.  Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium. , 2009, Oral Oncology.

[10]  B. Christensen,et al.  A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma , 2009, Cancer Prevention Research.

[11]  H. Morgenstern,et al.  Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium , 2009, Cancer Epidemiology Biomarkers & Prevention.

[12]  H. Morgenstern,et al.  Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. , 2009, American journal of epidemiology.

[13]  B. Sander,et al.  The endocannabinoid system in cancer-potential therapeutic target? , 2008, Seminars in cancer biology.

[14]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[15]  A. Hansell,et al.  Cannabis use and cancer of the head and neck: Case-control study , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[16]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Massi,et al.  Cannabinoids as potential new therapy for the treatment of gliomas , 2008, Expert review of neurotherapeutics.

[18]  C. Paraskeva,et al.  The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells , 2007 .

[19]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[20]  A. Olshan,et al.  Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). , 2006, Paediatric and perinatal epidemiology.

[21]  K. Altmann,et al.  New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors , 2006, Journal of receptor and signal transduction research.

[22]  Steven Gibson,et al.  Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  T. Klein.  Cannabinoid-based drugs as anti-inflammatory therapeutics , 2005, Nature Reviews Immunology.

[24]  H. Morgenstern,et al.  Epidemiologic review of marijuana use and cancer risk. , 2005, Alcohol.

[25]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[26]  M. Nagarkatti,et al.  Δ-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response1 , 2005, The Journal of Immunology.

[27]  N. Johnson,et al.  Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. , 2004 .

[28]  Sander Greenland,et al.  Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. , 2004, American journal of epidemiology.

[29]  K. Rosenblatt,et al.  Marijuana Use and Risk of Oral Squamous Cell Carcinoma , 2004, Cancer Research.

[30]  D. Lowy,et al.  A causal role for human papillomavirus in head and neck cancer , 2004, The Lancet.

[31]  N. Johnson,et al.  An analysis of risk factors for oral cancer in young people: a case-control study. , 2004, Oral oncology.

[32]  C. Newton,et al.  The cannabinoid system and immune modulation , 2003, Journal of leukocyte biology.

[33]  Jimmy D Bell,et al.  Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. , 2003, Oral oncology.

[34]  B. Buchan,et al.  Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. , 2002, Addiction.

[35]  Guo-Pei Yu,et al.  Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[36]  Li Zhu,et al.  Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1 , 2000, The Journal of Immunology.

[37]  H. Morgenstern,et al.  Marijuana use and increased risk of squamous cell carcinoma of the head and neck. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  G. Cabral,et al.  Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease , 1998, Journal of Neuroimmunology.

[39]  C. Carne,et al.  Oral sex and the transmission of viral STIs. , 1998, Sexually transmitted infections.

[40]  S Greenland,et al.  Basic methods for sensitivity analysis of biases. , 1996, International journal of epidemiology.

[41]  B. Perez-Ordonez,et al.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. , 2013, Oral oncology.

[42]  M. Gapany.  Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States , 2012 .

[43]  W. Xiao,et al.  Prevalence of Oral HPV Infection in the United States , 2009-2010 , 2012 .

[44]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[45]  A. C. Williams,et al.  The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. , 2007, International journal of cancer.

[46]  M. Nagarkatti,et al.  Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. , 2005, Journal of immunology.

[47]  Li Zhu,et al.  D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway , 2000 .

[48]  A. Howlett,et al.  Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. , 1999, Advances in experimental medicine and biology.

[49]  R. A. Johnson,et al.  Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. , 1998, American journal of public health.

[50]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[51]  J. Kaufman,et al.  Practice of Epidemiology Estimation of the Relative Excess Risk Due to Interaction and Associated Confidence Bounds , 2009 .